查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1609149

被忽視的熱帶疾病治療市場：按產品類型、疾病類型、診斷方法分類 - 全球預測 2025-2030

Neglected Tropical Disease Treatment Market by Product (Drugs, Vaccines), Types of Diseases (Buruli Ulcer, Chagas Disease, Dengue), Diagnostic Method - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

被忽視的熱帶疾病治療市場2023年估值為61.3億美元，預計到2024年將達到64億美元，複合年成長率為6.25%，預計到2030年將達到93.8億美元。

被忽視的熱帶疾病（NTD）是一組主要影響熱帶地區貧困階級並導致嚴重發病和社會恥辱的疾病。治療被忽視的熱帶疾病需要採取綜合方法，因為它對人們的健康、經濟生產力和社會結構有重大影響。這些措施包括醫療介入、病媒控制、公共衛生宣傳活動和社區教育。這包括疫苗、治療學和診斷工具中的應用。最終用途範圍從政府衛生機構到非營利組織再到參與藥物開發和分銷的私人公司。市場成長受到認知提高、流行地區醫療基礎設施改善以及促進藥物研究和生產的官民合作關係關係的影響。潛在的商機在於藥物發現技術的進步、國際組織增加的投資以及擴大覆蓋範圍和客製化治療的策略聯盟。為了利用這些優勢，相關人員應專注於加強研發能力，加強跨部門合作，並利用數位健康技術進行有效的疾病追蹤和病患管理。

主要市場統計
基準年[2023] 61.3億美元
預計年份 [2024] 64億美元
預測年份 [2030] 93.8億美元
複合年成長率（%） 6.25%

然而，該市場面臨基礎設施薄弱、資金不足和嚴格的監管控制等限制，阻礙了藥物的快速核准和分銷。受被忽視熱帶疾病影響最嚴重的地區的政治不穩定使干涉措施更加複雜。創新研究可以專注於開發綜合方法，將病原體基因組學結合起來進行個人化醫療、提高可及性的新藥物輸送系統以及治療和預防措施。您可以透過探索具有成本效益的生產技術和本地製造解決方案來減少對國際供應鏈的依賴，從而加速業務成長。 NTD 治療市場的本質是動態的，與醫療保健的進步和全球政策轉變相交叉，需要靈活的策略來應對不斷變化的挑戰。為了實現永續成長和影響力，進入開拓的公司必須跟上技術創新的步伐，加強國際合作，並開發適合當地需求和環境的產品和服務。

市場動態：針對快速發展的被忽視的熱帶疾病治療市場揭示的關鍵市場見解

供需的動態交互作用正在改變被忽視的熱帶疾病治療市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 人們對被忽視的熱帶疾病治療的認知不斷提高
    • 熱帶和亞熱帶國家被忽視的熱帶疾病負擔日益加重
    • 研發投入龐大
  • 市場限制因素
    • 藥物副作用
  • 市場機會
    • 政府的優惠待遇
    • 增加研發投資並推出新的治療方案
  • 市場挑戰
    • 缺乏標準化的診斷和治療工具

波特的五力：駕馭被忽視的熱帶疾病治療市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對被忽視的熱帶疾病治療市場的影響

外部宏觀環境因素在塑造被忽視的熱帶疾病治療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解被忽視的熱帶疾病治療市場的競爭格局

對被忽視的熱帶疾病治療市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 在被忽視的熱帶疾病治療市場中的定位矩陣供應商績效評估

FPNV 定位矩陣是評估被忽視的熱帶疾病治療市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了被忽視的熱帶疾病治療市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，被忽視的熱帶疾病治療市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人們越來越認知到被忽視的熱帶疾病的治療方法
      • 熱帶和亞熱帶國家經常被忽視的熱帶疾病的負擔增加
      • 龐大資金投入研發
    • 抑制因素
      • 藥物副作用
    • 機會
      • 政府的優惠待遇
      • 加大研發投入並推出新的治療方案
    • 任務
      • 缺乏標準化的診斷和治療工具
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章被忽視的熱帶疾病治療市場：依產品

  • 藥物
  • 疫苗

第7章依疾病類型分類的被忽視的熱帶疾病治療市場

  • 布魯裡潰瘍
  • 南美錐蟲病
  • 登革熱
  • 人類非洲錐蟲病
  • 利什曼原蟲症
  • 麻風
  • 狂犬病
  • 土源性蠕蟲病
  • 沙眼
  • 草莓瘤

第8章 診斷方法被忽視的熱帶疾病治療市場

  • 傳統的
  • 分子/現代

第9章 美洲被忽視的熱帶疾病治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區被忽視的熱帶疾病治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲被忽視的熱帶疾病治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Amneal Pharmaceuticals LLC
  • Bayer AG
  • Daiichi Sankyo Company, Limited
  • Eisai Co., Ltd.
  • F. Hoffmann-La Roche Ltd
  • Insud Pharma, SL
  • Novartis AG
  • Oblita Therapeutics
  • Omega Diagnostics Group PLC
  • Oscar Medicare Pvt Ltd.
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd
  • Themis Bioscience GmbH
  • Valneva SE
  • ZeptoMetrix, LLC
Product Code: MRR-AD36CD897E7F

The Neglected Tropical Disease Treatment Market was valued at USD 6.13 billion in 2023, expected to reach USD 6.40 billion in 2024, and is projected to grow at a CAGR of 6.25%, to USD 9.38 billion by 2030.

Neglected Tropical Diseases (NTDs) encompass a group of conditions primarily affecting impoverished populations in tropical regions, resulting in significant morbidity and social stigma. NTD treatment necessitates comprehensive efforts due to their profound impact on human health, economic productivity, and social structure. The scope encompasses medical intervention, vector control, public health campaigns, and community education. Applications include use in vaccines, therapeutic drugs, and diagnostic tools. End-use ranges from governmental health agencies to non-profits and private sector players involved in drug development and distribution efforts. Market growth is influenced by increased awareness, improved healthcare infrastructure in endemic regions, and public-private partnerships fostering pharmaceutical research and production. Potential opportunities lie in technological advancements in drug discovery, rising investments from international organizations, and strategic alliances aimed at broader coverage and tailored treatments. To capitalize on these, stakeholders should focus on enhancing R&D capabilities, reinforcing collaborations across sectors, and leveraging digital health technologies for efficient disease tracking and patient management.

KEY MARKET STATISTICS
Base Year [2023] USD 6.13 billion
Estimated Year [2024] USD 6.40 billion
Forecast Year [2030] USD 9.38 billion
CAGR (%) 6.25%

However, the market faces limitations due to infrastructural inadequacies, low funding, and stringent regulatory controls, which hinder swift drug approval and distribution. Political instability in regions most affected by NTDs further complicates efforts to deliver interventions. Innovative research can focus on pathogen genomics for personalized medicine, novel drug delivery systems to improve accessibility, and developing integrated approaches combining treatment with preventive measures. Business growth can be bolstered by exploring cost-effective production technologies and localized manufacturing solutions to reduce dependency on international supply chains. The nature of the NTD treatment market is dynamic, driven by the intersection of healthcare advances and global policy shifts, requiring agile strategies to address evolving challenges. Market players are advised to stay abreast of technological innovations, strengthen international collaborations, and adopt a bottom-up approach in developing products and services aligned with local needs and conditions, to achieve sustainable growth and impact.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neglected Tropical Disease Treatment Market

The Neglected Tropical Disease Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising awareness of neglected tropical diseases treatments
    • Increasing burden of neglected tropical disease in tropical and subtropical countries
    • Huge financial investment in research & development
  • Market Restraints
    • Side effects of the drugs
  • Market Opportunities
    • Favorable government initiatives for the treatment
    • Increasing investments in R&D and new launches in the treatment programs
  • Market Challenges
    • Lack of standardization tools for diagnosis and treatment

Porter's Five Forces: A Strategic Tool for Navigating the Neglected Tropical Disease Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neglected Tropical Disease Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neglected Tropical Disease Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neglected Tropical Disease Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neglected Tropical Disease Treatment Market

A detailed market share analysis in the Neglected Tropical Disease Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neglected Tropical Disease Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neglected Tropical Disease Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neglected Tropical Disease Treatment Market

A strategic analysis of the Neglected Tropical Disease Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neglected Tropical Disease Treatment Market, highlighting leading vendors and their innovative profiles. These include Amneal Pharmaceuticals LLC, Bayer AG, Daiichi Sankyo Company, Limited, Eisai Co., Ltd., F. Hoffmann-La Roche Ltd, Insud Pharma, S.L., Novartis AG, Oblita Therapeutics, Omega Diagnostics Group PLC, Oscar Medicare Pvt Ltd., Sanofi S.A, Teva Pharmaceutical Industries Ltd, Themis Bioscience GmbH, Valneva SE, and ZeptoMetrix, LLC.

Market Segmentation & Coverage

This research report categorizes the Neglected Tropical Disease Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Drugs and Vaccines.
  • Based on Types of Diseases, market is studied across Buruli Ulcer, Chagas Disease, Dengue, Human African trypanosomiasis, Leishmaniases, Leprosy, Rabies, Soil-transmitted Helminthiases, Trachoma, and Yaws.
  • Based on Diagnostic Method, market is studied across Conventional and Molecular/Modern.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising awareness of neglected tropical diseases treatments
      • 5.1.1.2. Increasing burden of neglected tropical disease in tropical and subtropical countries
      • 5.1.1.3. Huge financial investment in research & development
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects of the drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Favorable government initiatives for the treatment
      • 5.1.3.2. Increasing investments in R&D and new launches in the treatment programs
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of standardization tools for diagnosis and treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Neglected Tropical Disease Treatment Market, by Product

  • 6.1. Introduction
  • 6.2. Drugs
  • 6.3. Vaccines

7. Neglected Tropical Disease Treatment Market, by Types of Diseases

  • 7.1. Introduction
  • 7.2. Buruli Ulcer
  • 7.3. Chagas Disease
  • 7.4. Dengue
  • 7.5. Human African trypanosomiasis
  • 7.6. Leishmaniases
  • 7.7. Leprosy
  • 7.8. Rabies
  • 7.9. Soil-transmitted Helminthiases
  • 7.10. Trachoma
  • 7.11. Yaws

8. Neglected Tropical Disease Treatment Market, by Diagnostic Method

  • 8.1. Introduction
  • 8.2. Conventional
  • 8.3. Molecular/Modern

9. Americas Neglected Tropical Disease Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Neglected Tropical Disease Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Neglected Tropical Disease Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amneal Pharmaceuticals LLC
  • 2. Bayer AG
  • 3. Daiichi Sankyo Company, Limited
  • 4. Eisai Co., Ltd.
  • 5. F. Hoffmann-La Roche Ltd
  • 6. Insud Pharma, S.L.
  • 7. Novartis AG
  • 8. Oblita Therapeutics
  • 9. Omega Diagnostics Group PLC
  • 10. Oscar Medicare Pvt Ltd.
  • 11. Sanofi S.A
  • 12. Teva Pharmaceutical Industries Ltd
  • 13. Themis Bioscience GmbH
  • 14. Valneva SE
  • 15. ZeptoMetrix, LLC

LIST OF FIGURES

  • FIGURE 1. NEGLECTED TROPICAL DISEASE TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. NEGLECTED TROPICAL DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEGLECTED TROPICAL DISEASE TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY BURULI ULCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY CHAGAS DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DENGUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY HUMAN AFRICAN TRYPANOSOMIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY LEISHMANIASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY LEPROSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY RABIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY SOIL-TRANSMITTED HELMINTHIASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TRACHOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY YAWS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY MOLECULAR/MODERN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 151. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 152. NEGLECTED TROPICAL DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023